What is she best known for?
The fields of study she is best known for:
- Gene
- Genetics
- Biochemistry
Cell biology, Centrosome, Centriole, DNA repair and Ubiquitin ligase are her primary areas of study.
Her Cell biology research incorporates elements of Centriole assembly and Cytokinesis.
Her work deals with themes such as Cilium, Biogenesis and Biotinylation, which intersect with Centrosome.
Her Centriole study combines topics from a wide range of disciplines, such as Centriole elongation, Procentriole, Basal body, CEP135 and Pericentriolar material.
Her studies examine the connections between DNA repair and genetics, as well as such issues in Ubiquitin, with regards to Molecular biology.
Her work on Ubiquitin-conjugating enzyme as part of general Ubiquitin ligase study is frequently connected to MDC1 and G2-M DNA damage checkpoint, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Her most cited work include:
- Orchestration of the DNA-Damage Response by the RNF8 Ubiquitin Ligase (733 citations)
- Orchestration of the DNA-Damage Response by the RNF8 Ubiquitin Ligase (733 citations)
- The RIDDLE Syndrome Protein Mediates a Ubiquitin-Dependent Signaling Cascade at Sites of DNA Damage (586 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of investigation include Cell biology, Centrosome, Centriole, Mitosis and Centrosome cycle.
Her Cell biology research is multidisciplinary, incorporating perspectives in Spindle apparatus, Spindle pole body and Microtubule nucleation.
Laurence Pelletier has included themes like Biogenesis and Basal body in her Centrosome study.
Her studies deal with areas such as Procentriole, Centriole assembly and CEP135 as well as Centriole.
Her study in Mitosis is interdisciplinary in nature, drawing from both Tubulin, Mitotic exit and RNA interference.
Her Cancer research research also works with subjects such as
- Chromatin and related Ubiquitin,
- DNA repair that connect with fields like Ubiquitin-conjugating enzyme and Molecular biology.
She most often published in these fields:
- Cell biology (124.17%)
- Centrosome (72.50%)
- Centriole (38.33%)
What were the highlights of her more recent work (between 2018-2021)?
- Cell biology (124.17%)
- Centrosome (72.50%)
- Computational biology (15.83%)
In recent papers she was focusing on the following fields of study:
Laurence Pelletier spends much of her time researching Cell biology, Centrosome, Computational biology, Microtubule and Ciliogenesis.
The study incorporates disciplines such as PLK4 and Cell migration in addition to Cell biology.
Her Centrosome research integrates issues from Cancer research, Mitosis and Cell growth.
Her research in Computational biology intersects with topics in Proteome, Compartmentalization, Biotinylation, HEK 293 cells and Cellular compartment.
Laurence Pelletier usually deals with Ciliogenesis and limits it to topics linked to Biogenesis and Microtubule organizing center and Protein subcellular localization prediction.
Her studies in Actin integrate themes in fields like Flagellum and Basal body.
Between 2018 and 2021, her most popular works were:
- Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains (54 citations)
- Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains (54 citations)
- A proximity biotinylation map of a human cell (40 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Genetics
- Biochemistry
Her primary scientific interests are in Computational biology, Proteome, Organelle, Cellular compartment and HEK 293 cells.
Her Computational biology research is multidisciplinary, incorporating elements of Gene expression and BRD4.
The Proteome study combines topics in areas such as Compartment, Compartmentalization, Biotinylation and Intracellular.
Her study connects Human cell and Organelle.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
